Financials

  • Market Capitalization 401.93 M
  • Employee 120
  • Founded 1995
  • CEO N/A
  • Website www.enanta.com
  • Headquarter Massachusetts, United States
  • FIGI BBG001V9NSB4
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-3.12
Rapporto prezzo/fatturato
0

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3063
FENC
Fennec Pharmaceuticals Inc. - Common Stock
11.77 USD-3.29%+2.97%+17.00%+31.36%412.74 M USD
3071
LXEO
Lexeo Therapeutics, Inc. - Common Stock
4.78 USD-4.21%-5.53%+8.88%-0.62%392.18 M USD
3079
CTNM
Contineum Therapeutics, Inc. - Common stock
17.04 USD-1.22%+1.73%+20.25%+11.59%393.61 M USD
3080
RCKT
Rocket Pharmaceuticals, Inc. - Common Stock
3.75 USD+3.59%+5.34%+19.81%+12.28%411.65 M USD

Notizie